Selected research
Market Outlook & Growth Opportunities
Global Vitamins and Supplements for Joint Health Market Outlook and Growth Opportunities 2026
Market perspective
The global Vitamins and Supplements for Joint Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Vitamins and Supplements for Joint Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Vitamins and Supplements for Joint Health market include A&Z Pharmaceutical, Amway (Nutrilite), Bio Island, BioTrust Nutrition, Blackmores, Bluebonnet Nutrition, By-Health, GNC Holdings and GSK-Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Vitamins and Supplements for Joint Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vitamins and Supplements for Joint Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vitamins and Supplements for Joint Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Vitamins and Supplements for Joint Health market.
Vitamins and Supplements for Joint Health Segment by Company
A&Z Pharmaceutical
Amway (Nutrilite)
Bio Island
BioTrust Nutrition
Blackmores
Bluebonnet Nutrition
By-Health
GNC Holdings
GSK-Pfizer
Harbin Pharmaceutical Group
High Change
Nature Made
Nature's Bounty
NOW Foods
Pure Encapsulations
Schiff
Solgar
Bayer
Shanxi Zhendong Pharmaceutical
Vitamins and Supplements for Joint Health Segment by Type
Vitamins
Health Supplements
Vitamins and Supplements for Joint Health Segment by Application
Above 60 Years Old
50-60 Years Old
19-49 Years Old
Below 12 Years Old
12-18 Years Old
Vitamins and Supplements for Joint Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Vitamins and Supplements for Joint Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Vitamins and Supplements for Joint Health key companies, revenue, market share, and recent developments.
3. To split the Vitamins and Supplements for Joint Health breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Vitamins and Supplements for Joint Health market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Vitamins and Supplements for Joint Health significant trends, drivers, influence factors in global and regions.
6. To analyze Vitamins and Supplements for Joint Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamins and Supplements for Joint Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamins and Supplements for Joint Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamins and Supplements for Joint Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vitamins and Supplements for Joint Health industry.
Chapter 3: Detailed analysis of Vitamins and Supplements for Joint Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Vitamins and Supplements for Joint Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Vitamins and Supplements for Joint Health in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamins
- Health Supplements
Applications
- Above 60 Years Old
- 50-60 Years Old
- 19-49 Years Old
- Below 12 Years Old
- 12-18 Years Old
Companies covered
- A&Z Pharmaceutical
- Amway (Nutrilite)
- Bio Island
- BioTrust Nutrition
- Blackmores
- Bluebonnet Nutrition
- By-Health
- GNC Holdings
- GSK-Pfizer
- Harbin Pharmaceutical Group
- High Change
- Nature Made
- Nature's Bounty
- NOW Foods
- Pure Encapsulations
- Schiff
- Solgar
- Bayer
- Shanxi Zhendong Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vitamins and Supplements for Joint Health Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vitamins and Supplements for Joint Health Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Vitamins and Supplements for Joint Health Market Dynamics
- 2.1 Vitamins and Supplements for Joint Health Industry Trends
- 2.2 Vitamins and Supplements for Joint Health Industry Drivers
- 2.3 Vitamins and Supplements for Joint Health Industry Opportunities and Challenges
- 2.4 Vitamins and Supplements for Joint Health Industry Restraints
3 Vitamins and Supplements for Joint Health Market by Company
- 3.1 Global Vitamins and Supplements for Joint Health Company Revenue Ranking in 2025
- 3.2 Global Vitamins and Supplements for Joint Health Revenue by Company (2021-2026)
- 3.3 Global Vitamins and Supplements for Joint Health Company Ranking (2024-2026)
- 3.4 Global Vitamins and Supplements for Joint Health Company Manufacturing Base and Headquarters
- 3.5 Global Vitamins and Supplements for Joint Health Company Product Type and Application
- 3.6 Global Vitamins and Supplements for Joint Health Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Vitamins and Supplements for Joint Health Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Vitamins and Supplements for Joint Health Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Vitamins and Supplements for Joint Health Market by Type
- 4.1 Vitamins and Supplements for Joint Health Type Introduction
- 4.1.1 Vitamins
- 4.1.2 Health Supplements
- 4.2 Global Vitamins and Supplements for Joint Health Sales Value by Type
- 4.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Type (2021-2032)
- 4.2.3 Global Vitamins and Supplements for Joint Health Sales Value Share by Type (2021-2032)
5 Vitamins and Supplements for Joint Health Market by Application
- 5.1 Vitamins and Supplements for Joint Health Application Introduction
- 5.1.1 Above 60 Years Old
- 5.1.2 50-60 Years Old
- 5.1.3 19-49 Years Old
- 5.1.4 Below 12 Years Old
- 5.1.5 12-18 Years Old
- 5.2 Global Vitamins and Supplements for Joint Health Sales Value by Application
- 5.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Application (2021-2032)
- 5.2.3 Global Vitamins and Supplements for Joint Health Sales Value Share by Application (2021-2032)
6 Vitamins and Supplements for Joint Health Regional Value Analysis
- 6.1 Global Vitamins and Supplements for Joint Health Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vitamins and Supplements for Joint Health Sales Value by Region (2021-2032)
- 6.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Region: 2021-2026
- 6.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vitamins and Supplements for Joint Health Sales Value (2021-2032)
- 6.3.2 North America Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Vitamins and Supplements for Joint Health Sales Value (2021-2032)
- 6.4.2 Europe Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Vitamins and Supplements for Joint Health Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Vitamins and Supplements for Joint Health Sales Value (2021-2032)
- 6.6.2 South America Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Vitamins and Supplements for Joint Health Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
7 Vitamins and Supplements for Joint Health Country-level Value Analysis
- 7.1 Global Vitamins and Supplements for Joint Health Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Vitamins and Supplements for Joint Health Sales Value by Country (2021-2032)
- 7.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Country (2021-2026)
- 7.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.7.2 France Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.14.2 China Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.17.2 India Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 A&Z Pharmaceutical
- 8.1.1 A&Z Pharmaceutical Company Information
- 8.1.2 A&Z Pharmaceutical Business Overview
- 8.1.3 A&Z Pharmaceutical Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.1.4 A&Z Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio
- 8.1.5 A&Z Pharmaceutical Recent Developments
- 8.2 Amway (Nutrilite)
- 8.2.1 Amway (Nutrilite) Company Information
- 8.2.2 Amway (Nutrilite) Business Overview
- 8.2.3 Amway (Nutrilite) Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.2.4 Amway (Nutrilite) Vitamins and Supplements for Joint Health Product Portfolio
- 8.2.5 Amway (Nutrilite) Recent Developments
- 8.3 Bio Island
- 8.3.1 Bio Island Company Information
- 8.3.2 Bio Island Business Overview
- 8.3.3 Bio Island Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio Island Vitamins and Supplements for Joint Health Product Portfolio
- 8.3.5 Bio Island Recent Developments
- 8.4 BioTrust Nutrition
- 8.4.1 BioTrust Nutrition Company Information
- 8.4.2 BioTrust Nutrition Business Overview
- 8.4.3 BioTrust Nutrition Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.4.4 BioTrust Nutrition Vitamins and Supplements for Joint Health Product Portfolio
- 8.4.5 BioTrust Nutrition Recent Developments
- 8.5 Blackmores
- 8.5.1 Blackmores Company Information
- 8.5.2 Blackmores Business Overview
- 8.5.3 Blackmores Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.5.4 Blackmores Vitamins and Supplements for Joint Health Product Portfolio
- 8.5.5 Blackmores Recent Developments
- 8.6 Bluebonnet Nutrition
- 8.6.1 Bluebonnet Nutrition Company Information
- 8.6.2 Bluebonnet Nutrition Business Overview
- 8.6.3 Bluebonnet Nutrition Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.6.4 Bluebonnet Nutrition Vitamins and Supplements for Joint Health Product Portfolio
- 8.6.5 Bluebonnet Nutrition Recent Developments
- 8.7 By-Health
- 8.7.1 By-Health Company Information
- 8.7.2 By-Health Business Overview
- 8.7.3 By-Health Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.7.4 By-Health Vitamins and Supplements for Joint Health Product Portfolio
- 8.7.5 By-Health Recent Developments
- 8.8 GNC Holdings
- 8.8.1 GNC Holdings Company Information
- 8.8.2 GNC Holdings Business Overview
- 8.8.3 GNC Holdings Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.8.4 GNC Holdings Vitamins and Supplements for Joint Health Product Portfolio
- 8.8.5 GNC Holdings Recent Developments
- 8.9 GSK-Pfizer
- 8.9.1 GSK-Pfizer Company Information
- 8.9.2 GSK-Pfizer Business Overview
- 8.9.3 GSK-Pfizer Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.9.4 GSK-Pfizer Vitamins and Supplements for Joint Health Product Portfolio
- 8.9.5 GSK-Pfizer Recent Developments
- 8.10 Harbin Pharmaceutical Group
- 8.10.1 Harbin Pharmaceutical Group Company Information
- 8.10.2 Harbin Pharmaceutical Group Business Overview
- 8.10.3 Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.10.4 Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Product Portfolio
- 8.10.5 Harbin Pharmaceutical Group Recent Developments
- 8.11 High Change
- 8.11.1 High Change Company Information
- 8.11.2 High Change Business Overview
- 8.11.3 High Change Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.11.4 High Change Vitamins and Supplements for Joint Health Product Portfolio
- 8.11.5 High Change Recent Developments
- 8.12 Nature Made
- 8.12.1 Nature Made Company Information
- 8.12.2 Nature Made Business Overview
- 8.12.3 Nature Made Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.12.4 Nature Made Vitamins and Supplements for Joint Health Product Portfolio
- 8.12.5 Nature Made Recent Developments
- 8.13 Nature's Bounty
- 8.13.1 Nature's Bounty Company Information
- 8.13.2 Nature's Bounty Business Overview
- 8.13.3 Nature's Bounty Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.13.4 Nature's Bounty Vitamins and Supplements for Joint Health Product Portfolio
- 8.13.5 Nature's Bounty Recent Developments
- 8.14 NOW Foods
- 8.14.1 NOW Foods Company Information
- 8.14.2 NOW Foods Business Overview
- 8.14.3 NOW Foods Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.14.4 NOW Foods Vitamins and Supplements for Joint Health Product Portfolio
- 8.14.5 NOW Foods Recent Developments
- 8.15 Pure Encapsulations
- 8.15.1 Pure Encapsulations Company Information
- 8.15.2 Pure Encapsulations Business Overview
- 8.15.3 Pure Encapsulations Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.15.4 Pure Encapsulations Vitamins and Supplements for Joint Health Product Portfolio
- 8.15.5 Pure Encapsulations Recent Developments
- 8.16 Schiff
- 8.16.1 Schiff Company Information
- 8.16.2 Schiff Business Overview
- 8.16.3 Schiff Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.16.4 Schiff Vitamins and Supplements for Joint Health Product Portfolio
- 8.16.5 Schiff Recent Developments
- 8.17 Solgar
- 8.17.1 Solgar Company Information
- 8.17.2 Solgar Business Overview
- 8.17.3 Solgar Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.17.4 Solgar Vitamins and Supplements for Joint Health Product Portfolio
- 8.17.5 Solgar Recent Developments
- 8.18 Bayer
- 8.18.1 Bayer Company Information
- 8.18.2 Bayer Business Overview
- 8.18.3 Bayer Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.18.4 Bayer Vitamins and Supplements for Joint Health Product Portfolio
- 8.18.5 Bayer Recent Developments
- 8.19 Shanxi Zhendong Pharmaceutical
- 8.19.1 Shanxi Zhendong Pharmaceutical Company Information
- 8.19.2 Shanxi Zhendong Pharmaceutical Business Overview
- 8.19.3 Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
- 8.19.4 Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio
- 8.19.5 Shanxi Zhendong Pharmaceutical Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst